Review



fda cleared cloud based software platform  (Cleerly Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Cleerly Inc fda cleared cloud based software platform
    Fda Cleared Cloud Based Software Platform, supplied by Cleerly Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fda+cleared+cloud+based+software+platform/based+deep+learning+platform+software+validated/pm41421030-194-0-4
    Average 86 stars, based on 1 article reviews
    fda cleared cloud based software platform - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    Software:

    Article Title: Artificial intelligence in modern clinical practice (Review)
    Article Snippet: .. With automated analysis by a software platform (Cleerly Inc.), AI-QCT provides coronary artery wall and lumen specification alongside the quantification of plaques ( ). ..

    Article Title: The time-varying prognostic value of stenosis and plaque burden in coronary artery disease
    Article Snippet: .. A US Food and Drug Administration-approved artificial intelligence based software, atherosclerosis imaging-quantitative coronary computed tomography (AI-QCT, Cleerly Inc., Denver, CO, USA), was used to analyse the CCTA images. ..

    Article Title: Diagnostic Performance of AI-Assisted Coronary CT Angiography: A Systematic Review and Meta-Analysis.
    Article Snippet: .. FDA-cleared cloud-based software platform (Cleerly Labs, Cleerly).Uses deep learning and convolutional neural networks Invasive Quantitative Coronary Angiography 0 %, 1–49 %, 50–69 %, ≥70 %. ..

    Article Title: Health Plan-Based Atherosclerosis Imaging for Members with Diabetics: Utilization and Impact on Subsequent Episodes of Care.
    Article Snippet: All CCTA acquisitions were performed on scanners with 128 detector rows (Siemens Healthcare) per standard practice. .. CCTA images were then analyzed with AI-based software (Cleerly Inc). ..

    Article Title: Health Plan-Based Atherosclerosis Imaging for Members with Diabetics
    Article Snippet: All CCTA acquisitions were performed on scanners with 128 detector rows (Siemens Healthcare) per standard practice. .. CCTA images were then analyzed with AI-based software (Cleerly Inc). ..

    Computed Tomography:

    Article Title: Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis
    Article Snippet: .. Quantitative assessments used the Cleerly software platform (Cleerly LABS version 2.0, Cleerly Inc, New York, NY, USA), an FDA-cleared, cloud-based artificial intelligence tool for coronary computed tomography angiography analysis [ ]. .. Cleerly performs automated coronary segmentation, vessel boundary detection, and plaque identification.

    Article Title: The time-varying prognostic value of stenosis and plaque burden in coronary artery disease
    Article Snippet: .. A US Food and Drug Administration-approved artificial intelligence based software, atherosclerosis imaging-quantitative coronary computed tomography (AI-QCT, Cleerly Inc., Denver, CO, USA), was used to analyse the CCTA images. ..

    Article Title: Pericoronary adipose tissue as a biomarker of coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis.
    Article Snippet: .. Quantitative assessments used the Cleerly software platform (Cleerly LABS version 2.0, Cleerly Inc, New York, NY, USA), an FDA-cleared, cloud-based artificial intelligence tool for coronary computed tomography angiography analysis [27]. .. Cleerly performs automated coronary segmentation, vessel boundary detection, and plaque identification.

    Food & Beverages:

    Article Title: The time-varying prognostic value of stenosis and plaque burden in coronary artery disease
    Article Snippet: .. A US Food and Drug Administration-approved artificial intelligence based software, atherosclerosis imaging-quantitative coronary computed tomography (AI-QCT, Cleerly Inc., Denver, CO, USA), was used to analyse the CCTA images. ..

    Imaging:

    Article Title: The time-varying prognostic value of stenosis and plaque burden in coronary artery disease
    Article Snippet: .. A US Food and Drug Administration-approved artificial intelligence based software, atherosclerosis imaging-quantitative coronary computed tomography (AI-QCT, Cleerly Inc., Denver, CO, USA), was used to analyse the CCTA images. ..



    Similar Products

    fda cleared cloud based software platform  (Cleerly Inc)
    86
    Cleerly Inc fda cleared cloud based software platform
    Fda Cleared Cloud Based Software Platform, supplied by Cleerly Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fda+cleared+cloud+based+software+platform/based+deep+learning+platform+software+validated/pm41421030-194-0-4
    Average 86 stars, based on 1 article reviews
    fda cleared cloud based software platform - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier

    Image Search Results